Bicycle Therapeutics plc Total Long-Term Debt
Bicycle Therapeutics plc (BCYC) had Total Long-Term Debt of $30.91 million as of 2024-06-30, per its 10-Q filed 2024-08-06.
Financial Statements › Balance Sheet › Liabilities › Debt
us-gaap:LongTermDebt · last filed 2025-02-25
- 2024-06-30: Long-term Debt $30.91M.
- 2024-03-31: Long-term Debt $30.80M.
- 2023-12-31: Long-term Debt $30.70M.
- 2023-09-30: Long-term Debt $30.60M.
| Period end | Long-term Debt |
|---|---|
| 2024-06-30 | $30.91M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $30.80M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $30.70M 10-K · filed 2025-02-25 |
| 2023-09-30 | $30.60M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $30.51M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $30.42M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $30.32M 10-K · filed 2024-02-20 |
| 2022-09-30 | $30.23M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $30.14M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $30.01M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $29.87M 10-K · filed 2023-02-28 |
| 2021-09-30 | $29.75M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $29.63M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $29.50M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $14.51M 10-K · filed 2021-03-11 |
| 2020-09-30 | $14.43M 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |